These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 7530598)
1. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines. Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393 [TBL] [Abstract][Full Text] [Related]
3. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257 [TBL] [Abstract][Full Text] [Related]
4. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II. Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390 [TBL] [Abstract][Full Text] [Related]
5. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells. Gidlöf C; Dohlsten M; Kalland T; Tötterman TH Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852 [TBL] [Abstract][Full Text] [Related]
6. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526 [TBL] [Abstract][Full Text] [Related]
7. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity. Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632 [TBL] [Abstract][Full Text] [Related]
8. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice. Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731 [TBL] [Abstract][Full Text] [Related]
9. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells. Wahlsten JL; Mills CD; Ramakrishnan S J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706 [TBL] [Abstract][Full Text] [Related]
10. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803 [TBL] [Abstract][Full Text] [Related]
11. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor. Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269 [TBL] [Abstract][Full Text] [Related]
12. Naptumomab estafenatox, an engineered antibody-superantigen fusion protein with low toxicity and reduced antigenicity. Forsberg G; Skartved NJ; Wallén-Ohman M; Nyhlén HC; Behm K; Hedlund G; Nederman T J Immunother; 2010 Jun; 33(5):492-9. PubMed ID: 20463598 [TBL] [Abstract][Full Text] [Related]
13. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. Tiedemann RE; Fraser JD J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975 [TBL] [Abstract][Full Text] [Related]
15. Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes. Herrmann T; Romero P; Sartoris S; Paiola F; Accolla RS; Maryanski JL; MacDonald HR J Immunol; 1991 Apr; 146(8):2504-12. PubMed ID: 1707909 [TBL] [Abstract][Full Text] [Related]
16. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056 [TBL] [Abstract][Full Text] [Related]
17. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Brogan PA; Shah V; Klein N; Dillon MJ Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503 [TBL] [Abstract][Full Text] [Related]
18. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule. Lamphear JG; Stevens KR; Rich RR J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895 [TBL] [Abstract][Full Text] [Related]
19. Superantigen-mediated human monocyte-T lymphocyte interactions are associated with an MHC class II-, TCR/CD3-, and CD4-dependent mobilization of calcium in monocytes. Damaj B; Mourad W; Naccache PH J Immunol; 1992 Sep; 149(5):1497-503. PubMed ID: 1380531 [TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation. Nagasaki M; Zhang J; Morikawa S; Harada T; Nabika T; Tanaka Y Pathol Int; 2005 May; 55(5):264-72. PubMed ID: 15871724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]